Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells

Neurobiology of Aging

Volumn 30, Issue 9, 2009, Pages 1466-1476

  Zhang, Shuzhen ^a   Wang, Jun ^a   Song, Ning ^a   Xie, Junxia ^a   Jiang, Hong ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Apoptosis; Divalent metal transporter 1 (DMT1); Iron; Iron chelator; Iron regulatory protein (IRP); Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CASPASE 3; DEFEROXAMINE MESYLATE; FERROUS ION; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; IRON RESPONSIVE ELEMENT; IRON TRANSPORT; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR MECHANICS; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; CASPASE 3; CATION TRANSPORT PROTEINS; CELL LINE, TRANSFORMED; GENE EXPRESSION REGULATION; HERBICIDES; IRON; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIAL DISEASES; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE; RATS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; UP-REGULATION;

EID: 67650474704     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.11.025     Document Type: Article

References (50)

1. Andersen J.K. Iron dysregulation and Parkinson's disease. J. Alzheimers Dis. 6 (2004) S47-S52
2. Andrews N.C., Fleming M.D., and Gunshin H. Iron transport across biologic membranes. Nutr. Rev. 57 (1999) 114-123
3. Bayir H., Fadeel B., Palladino M.J., Witasp E., Kurnikov I.V., Tyurina Y.Y., Tyurin V.A., Amoscato A.A., Jiang J., Kochanek P.M., DeKosky S.T., Greenberger J.S., Shvedova A.A., and Kagan V.E. Apoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondria. Biochim. Biophys. Acta 1757 (2006) 648-659
4. Berg D., and Hochstrasser H. Iron metabolism in Parkinsonian syndromes. Mov. Disord. 21 (2006) 1299-1310
5. Bredesen D.E., Rao R.V., and Mehlen P. Cell death in the nervous system. Nature 443 (2006) 796-802
6. Breuer W., Epsztejn S., and Cabantchik Z.I. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J. Biol. Chem. 270 (1995) 24209-24215
7. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., Haile D.J., Beard J.L., and Connor J.R. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66 (2001) 1198-1207
8. Crawford Jr. G.D., Le W.D., Smith R.G., Xie W.J., Stefani E., and Appel S.H. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12 (1992) 3392-3398
9. Deguil J., Jailloux D., Page G., Fauconneau B., Houeto J.L., Philippe M., Muller J.M., and Pain S. Neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in MPP(+)-induced alteration of translational control in Neuro-2a neuroblastoma cells. J. Neurosci. Res. 85 (2007) 2017-2025
10. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., and Marsden C.D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52 (1989) 1830-1836
11. Dexter D.T., Sian J., Jenner P., and Marsden C.D. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. Adv. Neurol. 60 (1993) 273-281
12. Gal S., Zheng H., Fridkin M., and Youdim M.B. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion. J. Neurochem. 95 (2005) 79-88
13. Gotz M.E., Double K., Gerlach M., Youdim M.B., and Riederer P. The relevance of iron in the pathogenesis of Parkinson's disease. Ann. NY Acad. Sci. 1012 (2004) 193-208
14. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., and Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388 (1997) 482-488
15. Hardy P.A., Gash D., Yokel R., Andersen A., Ai Y., and Zhang Z. Correlation of R2 with total iron concentration in the brains of rhesus monkeys. J. Magn. Reson. Imaging 21 (2005) 118-127
16. Huang E., Ong W.Y., and Connor J.R. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience 128 (2004) 487-496
17. Hubert N., and Hentze M.W. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12345-12350
18. Jantova S., Cipak L., and Letasiova S. Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. Toxicol. In Vitro 21 (2007) 25-31
19. Jiang H., Qian Z.M., and Xie J.X. Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice. Sheng Li Xue Bao. 55 (2003) 571-576
20. Jiang H., Luan Z., Wang J., and Xie J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem. Int. 49 (2006) 605-609
21. Jiang H., Song N., Wang J., Ren L.Y., and Xie J.X. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem. Int. (2007)
22. Kalivendi S.V., Kotamraju S., Cunningham S., Shang T., Hillard C.J., and Kalyanaraman B. 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. Biochem. J. 371 (2003) 151-164
23. Kamp D.W., Panduri V., Weitzman S.A., and Chandel N. Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals. Mol. Cell Biochem. 234-235 (2002) 153-160
24. Ke Y., Chang Y.Z., Duan X.L., Du J.R., Zhu L., Wang K., Yang X.D., Ho K.P., and Qian Z.M. Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain. Neurobiol. Aging 26 (2005) 739-748
25. Knutson M., Menzies S., Connor J., and Wessling-Resnick M. Developmental, regional, and cellular expression of SFT/UbcH5A and DMT1 mRNA in brain. J. Neurosci. Res. 76 (2004) 633-641
26. Lan J., and Jiang D.H. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J. Neural Transm. 104 (1997) 469-481
27. Lee P.L., Gelbart T., West C., Halloran C., and Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol. Dis. 24 (1998) 199-215
28. Mackenzie B., Takanaga H., Hubert N., Rolfs A., and Hediger M.A. Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem. J. 403 (2007) 59-69
29. May J.M., Qu Z.C., and Mendiratta S. Role of ascorbic acid in transferrin-independent reduction and uptake of iron by U-937 cells. Biochem. Pharmacol. 57 (1999) 1275-1282
30. Moos T., and Morgan E.H. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann. NY Acad. Sci. 1012 (2004) 14-26
31. Picard V., Govoni G., Jabado N., and Gros P. Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool. J. Biol. Chem. 275 (2000) 35738-35745
32. Poirier J., Donaldson J., and Barbeau A. The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals. Biochem. Biophys. Res. Commun. 128 (1985) 25-33
33. Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynolds G.P., Jellinger K., and Youdim M.B. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52 (1989) 515-520
34. Rouault T.A. Iron on the brain. Nat. Genet. 28 (2001) 299-300
35. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2 (2006) 406-414
36. Ryu J.W., Hong K.H., Maeng J.H., Kim J.B., Ko J., Park J.Y., Lee K.U., Hong M.K., Park S.W., Kim Y.H., and Han K.H. Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 864-870
37. Sanelli T., Ge W., Leystra-Lantz C., and Strong M.J. Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant. J. Neurol. Sci. 256 (2007) 39-51
38. Song N., Jiang H., Wang J., and Xie J.X. Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J. Neurosci. Res. 85 (2007) 3118-3126
39. Temlett J.A., Landsberg J.P., Watt F., and Grime G.W. Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis. J. Neurochem. 62 (1994) 134-146
40. Tenopoulou M., Doulias P.T., Barbouti A., Brunk U., and Galaris D. Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem. J. 387 (2005) 703-710
41. Trinder D., Oates P.S., Thomas C., Sadleir J., and Morgan E.H. Localisation of divalent metal transporter 1 (DMT1) to the microvillus membrane of rat duodenal enterocytes in iron deficiency, but to hepatocytes in iron overload. Gut 46 (2000) 270-276
42. Wang J., Jiang H., and Xie J.X. Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system. Neurochem. Res. 29 (2004) 2239-2243
43. Wang J., Jiang H., and Xie J.X. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats. Eur. J. Neurosci. 25 (2007) 2766-2772
44. Wardrop S.L., and Richardson D.R. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake. Eur. J. Biochem. 263 (1999) 41-49
45. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231 (1991) 482-497
46. Wetli H.A., Buckett P.D., and Wessling-Resnick M. Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. Chem. Biol. 13 (2006) 965-972
47. Xie J., Jiang H., Chen W.F., and Qian Z.M. Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease. Exp. Neurol. 182 (2003) 483-489
48. Yang J., Su Y., and Richmond A. Antioxidants tiron and N-acetyl-l-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway. Free Radic. Biol. Med. 42 (2007) 1369-1380
49. Yao G., Yang L., Hu Y., Liang J., and Hou Y. Nonylphenol-induced thymocyte apoptosis involved caspase-3 activation and mitochondrial depolarization. Mol. Immunol. 43 (2006) 915-926
50. Zhu H.J., and Liu G.Q. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism. Life Sci. 75 (2004) 1313-1322